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Pioneering biochemical studies have long forged the
concept that the mitochondria are the ‘energy pow-
erhouse of the cell’. These studies, combined with
the unique evolutionary origin of the mitochondria,
led the way to decades of research focusing on the
organelle as an essential, yet independent, func-
tional component of the cell. Recently, however,
our conceptual view of this isolated organelle has
been profoundly altered with the discovery that mito-
chondria function within an integrated reticulum that
is continually remodeled by both fusion and fission
events. The identification of a number of proteins
that regulate these activities is beginning to provide
mechanistic details of mitochondrial membrane
remodeling. However, the broader question remains
regarding the underlying purpose of mitochondrial
dynamics and the translation of these morphological
transitions into altered functional output. One hy-
pothesis has been that mitochondrial respiration
and metabolism may be spatially and temporally reg-
ulated by the architecture and positioning of the or-
ganelle. Recent evidence supports and expands
this idea by demonstrating that mitochondria are
an integral part of multiple cell signaling cascades.
Interestingly, proteins such as GTPases, kinases
and phosphatases are involved in bi-directional
communication between the mitochondrial reticu-
lum and the rest of the cell. These proteins link mito-
chondrial function and dynamics to the regulation of
metabolism, cell-cycle control, development, antivi-
ral responses and cell death. In this review we will
highlight the emerging evidence that provides mo-
lecular definition to mitochondria as a central plat-
form in the execution of diverse cellular events.
Introduction
The biochemistry of mitochondria has been the sub-
ject of intense investigation over the past 50 years.
Within these organelles, sugars and long chain fatty
acids are broken down, ADP is recycled back into
ATP, steroids and lipids are synthesized, ancient
DNA is replicated, transcribed and proteins are trans-
lated, along with numerous other reactions that are es-
sential for human life. From a structural perspective,
the mitochondrion is unusual since it contains two
membranes that separate four distinct compartments,
the outer membrane, intermembrane space, inner
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2 These authors contributed equally.membrane and the matrix. The inner membrane is
highly folded into cristae, which house the megadalton
complexes of the electron transport chain and ATP
synthase that control the basic rates of cellular metab-
olism. For the most part, the biochemistry of this or-
ganelle has been investigated in cell-free, isolated sys-
tems, leading us to imagine the mitochondrion as
a lonely participant in the cell working tirelessly to pro-
vide the energy required for life. In the past 10 years,
this view has changed as newer approaches have al-
lowed the examination of dynamic mitochondrial func-
tion and behavior in response to cellular signals within
intact cells. We now understand that mitochondria
form a functional reticulum whose steady-state mor-
phology is regulated by dynamic fission, fusion and
motility events. Multiple proteins are involved in the re-
modeling of mitochondrial membranes [1]. Mitochon-
drial fusion is mediated through the action of at least
three GTPases. Mitofusin 1 (Mfn1) and Mitofusin 2
(Mfn2) are integrated within the mitochondrial outer
membrane, with their GTPase and coiled-coil domains
exposed to the cytosol [2]. Mfn1 and Mfn2 exist as ho-
motypic and heterotypic complexes that can form be-
tween adjacent organelles [3,4]. Mechanistically, it has
been suggested that the carboxy-terminal coiled coils
tether two organelles undergoing fusion, with the
GTPase domains probably regulating the fusion reac-
tion (Figure 1) [5–7]. Another dynamin-like GTPase,
Opa1, resides in the intermembrane space, where it
is associated with the inner membrane [8–10]. Opa1
exists as multiple splice and cleavage variants and
its function in mitochondrial fusion has been linked
genetically to that of Mfn1 (Figure 1) [11,12]. Mitochon-
drial fission relies on yet another GTPase from the
dynamin family, DRP1 [13–15]. By analogy with dyna-
mins, it has been suggested that DRP1 oligomerizes
into ring-like structures around the fission sites, to
constrict the organelle in a GTP-dependent manner.
In fact, DRP1 forms puncta on the mitochondrial mem-
brane, some of which mark future fission sites. The
mechanism of recruitment of DRP1 into active fission
complexes remains unclear, however. Also, other pro-
teins have been demonstrated to function in tandem
with the GTPases described above, and thus have
been directly or indirectly linked to fission and fusion
[1]. These proteins are listed in Table S1 (see Supple-
mental data published with this article online) and
some of their roles in mitochondrial membrane remod-
eling as well as their wider impact on cellular events
will be discussed below.
The identification and characterization of the protein
machinery that controls mitochondrial membrane dy-
namics constitutes an important step towards a better
understanding of mitochondrial behavior. Mitochon-
dria are an integrated component of the cell and their
actions are undoubtedly linked to cellular activities.
The current focus of research within this field is to
identify precise molecular links between mitochondrial
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Figure 1. Regulation of mitochondrial me-
tabolism through morphological changes
and signaling. (A) Phosphorylation and
dephosphorylation of metabolic enzymes,
including subunits of the respiratory com-
plexes I-V are modulated by calcium-me-
diated signaling. (B) In the mitochondrial
matrix, phosphorylation and dephosphor-
ylation of pyruvate dehydrogenase (PDH)
are regulated through concerted actions
of PDH kinases (PDK) and phosphatases
(PDP). The activity of PDH is also modu-
lated by a cytosolic signaling cascade
that converges onto GSK-3b, leading to
PDH dephosphorylation and activation,
ultimately promoting metabolic activity.
(C) The fusion GTPase Mfn2 regulates me-
tabolism, electrochemical potential and
expression of the respiratory complexes
through unknown signaling partners. (D)
Membrane fusion facilitates the propaga-
tion of metabolites, such as calcium, reac-
tive oxygen species and mitochondrial
DNA (mtDNA), within the mitochondrial re-
ticulum. The GTPases Mfn1, Mfn2 and
Opa1 coordinate the reaction of mitochon-
drial membrane fusion. Mfn proteins are
required on both sides of the membrane,
with Mfn1 mediating membrane tethering.
Solid lines indicate protein interactions
and reaction pathways, dotted lines repre-
sent protein and metabolite translocation
events. See text for details and references.function and the machinery that governs morphology.
In addition, recent evidence suggests that bi-direc-
tional signaling exists between mitochondria and other
cellular components. The implication of the GTPase
switch, both regulatory and mechanical, in the gover-
nance of mitochondrial dynamics has recently been
shown to couple mitochondrial function to cellular de-
mand. This integration allows mitochondrial function,
localization and biogenesis to be responsive to
changes in cell metabolism, development, death and
division. These new insights into mitochondrial biology
reveal a more central function for this organelle than
previously appreciated and constitute the focus of
this review.
Regulation of Metabolism
Recent evidence demonstrates that the machinery that
governs mitochondrial dynamics also participates in
the temporal regulation of metabolism (Figure 1).
These findings may not be surprising since the assem-
bly of the mitochondrial cristae and apparent conden-
sation of the matrix space observed by electron mi-
croscopy has been long considered to reflect the
metabolic state of mitochondria [16,17]. In more recent
years, tomographic reconstructions of isolated mito-
chondria revealed a detailed variety of cristae mor-
phologies, from simple tubular structures to large,
flat lamella and vacuolated intercristal spaces [18,19].
The dynamic shift in morphology coincides with a num-
ber of physiological events, such as transitions be-
tween different respiratory states and cristae remodel-
ing during apoptosis [18,20,21]. Consistent with this,
the loss or mutation of some inner membrane proteins
affects cristae morphology and results in reducedrespiration. For example, lack of non-essential sub-
units within the ATP synthase in yeast leads to the
loss of cristae with the inner membrane forming ring
structures within the mitochondria [22–24]. Similarly,
deletion of the intermembrane space GTPase Opa1
causes vesiculation of the inner membrane, and loss
of the inner-membrane-anchored Mitofilin leads to
concentric sheets of inner membrane ring structures.
In all these cases, aberrations in cristae morphology
are accompanied by alterations in metabolism [9,25–
27]. Furthermore, cells lacking Opa1 or Mitofilin are
highly susceptible to apoptotic death, indicating the
importance of maintaining inner membrane morphol-
ogy [9,27]. The details of how these proteins contribute
to the inner membrane architecture are unknown, but
these findings illustrate the fact that cristae do not
form spontaneously and are created by active, regu-
lated processes. A number of other proteins required
for the maintenance of inner membrane morphology
have been identified from genetic screens in yeast
[28–30], and are listed in Table S1.
Recent evidence suggests that mitochondrial fis-
sion and fusion also regulate mitochondrial metabo-
lism. The downregulation of Opa1 or both Mitofusin
GTPases by RNA interference leads to fragmented
mitochondria with greatly reduced oxygen consump-
tion and electrochemical potential [26]. Although all
three GTPases are known components of the mito-
chondrial fusion machinery [31], they are not directly
linked to the metabolic machineries. Therefore it is
unclear why the loss of these fusion proteins interferes
with respiration. This effect is specific to the loss of the
fusion proteins rather than the morphological transition
alone since mitochondrial fragmentation induced upon
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lism [26]. The metabolic dysfunction that characterizes
fusion-incompetent mitochondria may be secondary
to a requirement for exchange of specific cargo, for ex-
ample mitochondrial DNA (mtDNA), calcium, and other
metabolites (Figure 1). Complementation of mtDNA
has been demonstrated to be one important aspect
of mitochondrial fusion, since the nucleoids carrying
the mtDNA are shared within the dynamic reticulum
[32–35]. If a block in fusion results in small mitochon-
dria that either completely lack mtDNA or become
enriched with mutant mtDNA, these mitochondria
would ultimately lose their functional electron trans-
port chain, leading to compromised oxygen consump-
tion. Interestingly, cells lacking Mfn1 and Mfn2 were
maintained only in supplemented media containing
high pyruvate and uridine, conditions that are also
required to maintain rho0 cells lacking mtDNA [26]. In
addition to the sharing of cargo, the fusion machinery
may be required either directly or indirectly for the
maintenance of inner membrane cristae dynamics,
which, as mentioned above, regulate mitochondrial
metabolism.
Consistent with the evidence that the loss of the fu-
sion machinery leads to reduced metabolism, it has
been recently demonstrated that overexpression of
Mfn2 in cultured cells leads to an upregulation of the
respiratory complexes, mitochondrial oxidation and
glucose utilization by cells [36,37]. Interestingly, the
expression of a fusion-deficient form of Mfn2 also in-
creases the respiratory capacity with accompanying
condensation of the cristae, suggesting that Mfn2
may have a role in metabolic regulation that is distinct
from its role in fusion [37]. In addition, Mfn2 mRNA and
protein expression within skeletal muscle is reduced in
the Zucker rat model of obesity [36,37] and in human
subjects with obesity and diabetes [38], highlighting
the pathological implications of aberrant mitochon-
drial dynamics. Changes in Mfn2 expression are ac-
companied by altered mitochondrial network in vivo
and reduced metabolism in vitro [37].
Experiments investigating the mitochondrial fission
machinery are also consistent with the emerging func-
tional link between the morphology and metabolic
output of mitochondria. Cells exposed to high levels
of glucose contain highly fragmented mitochondria
[39,40] that are hyperpolarized and generate a transient
increase in reactive oxygen species (ROS) production
as a result of the increased respiration. Interestingly,
the fragmentation event requires glucose entry into
the cell, but precedes pyruvate uptake by mitochon-
dria, placing it as an early event [40]. Importantly, the
observed transition in mitochondrial morphology and
increased ROS production return to baseline within
60 minutes, indicating that the process is reversible.
In cells overexpressing Mfn2 or a dominant-interfering
mutant of the mitochondrial DRP1, the mitochondria
remain tubular and do not show any increased respira-
tion, hyperpolarization or ROS production [40]. These
data indicate that mitochondrial fragmentation is re-
quired for the hyperglycemia-induced increase in res-
piration. Interestingly, chronic hyperglycemia, as in the
diabetic condition, results in downregulation of Mfn2 in
muscle cells, which is consistent with a more stabletransition of the mitochondria to the fragmented state
[36,38]. Taken together, this accumulating evidence
supports the idea that the machineries that govern mi-
tochondrial fusion and fission are intimately coupled to
the metabolic processes within the organelle.
Mitochondrial Kinases and Phosphatases
in Metabolic Regulation
Given that there are no direct links between the fusion/
fission machineries and the metabolic complexes, the
obvious question that arises is how are these morpho-
logical transitions translated into altered metabolic
output? One possibility is that the morphology ma-
chinery might be integrated into pathways that regu-
late post-translational modifications of the metabolic
complexes. Experiments published almost 40 years
ago demonstrated that phosphorylation of the ma-
trix-localized pyruvate dehydrogenase (PDH) complex
inhibits the conversion of pyruvate to acetyl Co-A, the
first step in the citric acid cycle [41]. PDH kinases 1–4
were later identified and their expression is now known
to be tightly controlled through transcriptional regula-
tion [42]. For example, they are upregulated during
starvation when they efficiently phosphorylate PDH,
resulting in the inactivation of the enzyme when the
substrate levels are low [43]. Interestingly, a mecha-
nism for a rapid regulation of PDH has been uncovered
that may complement the activity of the PDH kinases.
Insulin stimulation activates protein kinase B/Akt in
a phosphatidylinositol (PI) 3-kinase-dependent man-
ner [44]. Akt controls a number of metabolic and sur-
vival pathways and was recently found to translocate
into the mitochondrial matrix in response to insulin
stimulation [45]. A known target of activated Akt is gly-
cogen synthase kinase 3b (GSK-3b) [46], which, al-
though mainly cytosolic, has also been found within
mitochondria [47]. The non-phosphorylated form of
GSK-3b is an active kinase that, among other sub-
strates, targets PDH, leading to reduced metabolic ac-
tivity [48]. Phosphorylation of GSK-3b by Akt inhibits
its kinase activity, which allows PDH to be dephos-
phorylated and therefore activated, leading to an in-
crease in metabolism. Although these data require fur-
ther substantiation, it represents a mechanism for the
dynamic regulation of metabolic components by ex-
tracellular stimuli.
Very recently the mitochondrial phosphoproteome
was shown to be much more extensive than previously
anticipated and, remarkably, there was a dynamic
change in the phosphorylation state of numerous pro-
teins in response to calcium signaling [49]. The mi-
tochondrial response to calcium flux has long been
considered a central aspect of its morphology and
function, both as a calcium buffer and in the propaga-
tion of intracellular calcium waves during muscle con-
traction and synaptic vesicle release [50–53]. The pro-
teins phosphorylated in response to calcium include
many components of the electron transport chain
and the citric acid cycle [49], indicating that multiple
mitochondrial kinases and phosphatases regulate mi-
tochondrial function in a dynamic manner (Table S1).
The recent identification of a novel phosphatase,
termed PTPMT1, as a permanent resident of the mito-
chondrial matrix compartment provides insights into
Review
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PTPMT1 by RNA interference leads to an almost two-
fold increase in ATP production and increases the ki-
netics of insulin release both at steady state and
upon glucose stimulation [54]. Although substrates of
this phosphatase within the matrix have not yet been
identified, components of the electron transport chain
and ATP synthase are obvious candidates. Many cyto-
solic kinases have been found to associate specifically
with the mitochondrial surface under different condi-
tions [55]. These kinases include members of the Src
family, whose mitochondrial localization has also
been shown to affect oxidative metabolism and cell
signaling [56–58]. Two new mitochondrial kinases
have also been recently identified, the intermembrane
space PTEN-induced kinase 1 (PINK1) [59,60], and
the peripherally associated leucine rich repeat kinase
2 (LRRK2) [61,62]. The substrates and function of
PINK1 and LRRK2 are currently unknown; however,
both proteins are affected in Parkinson’s disease, high-
lighting the importance of mitochondrial phosphoryla-
tion in human pathophysiology. In addition, PINK1 was
recently found to interact genetically with a third Par-
kinson’s disease gene, Parkin [63,64], which encodes
a cytosolic ubiquitin E3 ligase that has been found in
the mitochondrial matrix of dividing cells [65]. Future
experiments will confirm whether the machinery that
regulates mitochondrial morphology is functionally
linked to metabolic regulation through post-transla-
tional modifications such as phosphorylation.
Mitochondria and the Cell Cycle
It is understood that functional mitochondria are re-
quired for all cell processes due to common energetic
requirements. Recent data expand on this require-
ment, however, and place the emphasis on this organ-
elle as a relevant signaling platform for cell-cycle pro-
gression. For example, two important studies have
recently defined the molecular basis for the previously
observed cell-cycle arrest under conditions of low en-
ergy. AMPK is a heterotrimeric kinase that is activated
in high AMP conditions, making it a sensor of the
AMP:ATP ratio [66]. Upon activation of AMPK, a phos-
phorylation cascade is initiated that alters both con-
sumption and production of ATP. Recently, activated
AMPK was shown to phosphorylate Ser15 of p53
[67], a modification that is known to protect the protein
from degradation and promote cell-cycle arrest during
DNA damage and aberrant growth factor signaling [68].
Upon deletion of p53, nutrient deprivation results in
continued cellular proliferation, with an eventual loss
in cell viability, confirming the essential requirement
for p53 in nutrient-dependent cell-cycle arrest [67].
This discovery has led to a more precise mechanistic
understanding of how low glucose and ATP leads to
cell-cycle arrest and promotes cell survival [67]. In a
series of experiments expanding on this theme in
Drosophila, it was demonstrated that defects in the
cytochrome oxidase subunit Va (CoVa) induced a
cell-cycle arrest in the developing eye [69]. Surpris-
ingly, the reduction in ATP production observed in
the CoVa mutant was not sufficient to arrest cell growth
or interfere with the differentiation program, since cells
within the eye showed many hallmark features ofdifferentiated neurons, rod and cone cells. Consistent
with the work of Jones et al. [67], the block in cell divi-
sion was due to the activation of AMPK and sub-
sequent phosphorylation of p53, leading to the loss
of cyclin E and cell-cycle arrest at the G1 to S phase
transition. Interestingly, the Drosophila study proved
that the secondary loss of either AMPK or p53 along
with CoVa rescued progression from G1 to S phase,
despite lower ATP production [69]. Together, these
data define a novel low-energy cell-cycle checkpoint
that monitors the metabolic activity of the mito-
chondria before committing to another round of cell
division.
In addition to the metabolic control of cell-cycle
transition, efforts have been made to identify cell-
cycle-dependent mechanisms that regulate mitochon-
drial inheritance during mitosis. In the yeast Candida
albicans, it has been observed that the mitochondria
fragment upon entrance into M phase [70]. Genetic
screens were then developed to identify factors re-
quired for these morphological transitions in Saccha-
romyces cerevisiae. These screens examined mito-
chondrial morphology and positioning, and were the
first to uncover many genes responsible for mitochon-
drial fission and fusion, as well as those implicated in
the targeted migration of mitochondria into the bud
[28,31,71–75]. However, even with this new list of es-
sential proteins, it remains unclear how the machinery
that mediates movement and division is modulated
during the cell cycle. In addition to changes during mi-
tosis, yeast mitochondria form a highly fused reticulum
that is tightly associated with the nucleus during meio-
sis [76]. In the late tetrad state, just prior to sporulation,
the mitochondria are again highly fragmented, a pro-
cess that is required for the formation of viable spores
[77]. In addition, one of the yeast proteins required for
mitochondrial fusion, Fuzzy Onion (Fzo1p) is actively
degraded by a proteasome-dependent process during
mating, in response to G-protein-coupled receptor
signaling initiated by the yeast a-mating factor [78].
Together, these data show that the machinery that
governs mitochondrial morphology is intimately linked
with the signaling cascades that initiate cell-cycle and
mating transitions. In the mammalian system, overex-
pression of Mfn2, in addition to stimulating mitochon-
drial fusion, induces a cell-cycle arrest at the G1 to S
transition [79]. An examination of the upstream signals
affected by the expression of Mfn2 reveals that, upon
addition of epidermal growth factor, the Ras GTPase
is not activated and the ERK phosphorylation cascade
is not engaged. The inhibition of proliferation and lack
of ERK activation occurs even following expression
of a form of Mfn2 that is not targeted to the mito-
chondria, arguing for a specific signaling role of Mfn2
in cell-cycle arrest [79]. These data suggest that
Mfn2 is able to interfere with very early signaling events
following receptor–ligand binding. It is unclear why
this GTPase would have any effect on signaling pro-
teins like Ras, but it is interesting to note that Ras
and some of the downstream signaling effectors in
this pathway, including ERK1/2, have been localized
to the mitochondria (Table S1). Further studies are
required to provide more conclusive insights into
these mechanisms.
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Unexpected Guests: K-Ras, p53 and NF-kB
Signaling on the Mitochondria
Perhaps the best known example of the integration of
mitochondria within an established signaling pathway
is their central function within the apoptotic cascade.
Morphologically, it has been determined that mito-
chondrial fragmentation and cristae remodeling are
essential steps for cytochrome c release and cell death
[80,81]. The field of apoptosis has been witness to
a growing list of proteins that translocate to the mito-
chondria in a highly synchronized fashion, in addition
to those that are systematically released from mito-
chondria in the dramatic cascade of events required
to neatly package a dead cell. Interestingly, one of
the key signal transduction GTPases, K-Ras, is a new
addition to the list of proteins that translocate to the
mitochondria and induce cell death [82]. K-Ras is pri-
marily localized to the plasma membrane; however,
upon phosphorylation by protein kinase C, a conforma-
tional change results in its extraction from the plasma
membrane and rapid recruitment to the mitochondria
[82]. Once positioned there, K-Ras interacts with Bcl-
XL to promote activation-induced apoptosis of T cells
[82]. The pro-death effects of mitochondrial-associ-
ated K-Ras are not completely understood, although
its interactions with anti-apoptotic proteins like Bcl-
XL and Bcl-2 may result in their sequestration and inac-
tivation. Interestingly, this is not the first report of the
recruitment of Ras family proteins to the mitochondria
[83] and is consistent with the growing list of signaling
adaptors and enzymes that can be found in mitochon-
drial fractions either biochemically or by fluorescence
microscopy (Table S1). Given that K-Ras is known to
partition selectively into lipid-based microdomains
[84,85], it is possible that it could bring associated pro-
teins, like Bcl-XL, into a novel type of mitochondrial
platform that would change their functional activity. It
is also conceivable that there are mitochondrial
K-Ras exchange factors, GTPase activating proteins
and effectors that may control the nucleotide state
and function of Ras during its mitochondrial residence.
In addition to K-Ras, the nuclear transcription factor
p53 was found to translocate to the mitochondria dur-
ing cell death and to interact directly with the anti-apo-
ptotic proteins Bcl-2 and Bcl-XL [86]. Unlike K-Ras,
mitochondrial p53 has also been shown to participate
in the cytosolic activation of Bax, oligomerization of
Bax and Bak and subsequent cytochrome c release
[87]. The dynamic translocation of K-Ras and p53
to the mitochondria highlight the dual functionality of
signaling proteins and their role in mitochondrial
biology.
In the field of immunology, four independent groups
recently identified a new mammalian protein called
MAVS (mitochondrial anti-viral signaling protein).
MAVS is an integral outer membrane protein that plays
a central role in the signal transduction cascades that
lead to the NF-kB stress response and type 1 inter-
feron response [88–91]. MAVS functions as an adaptor
between the viral-dsRNA-binding protein RIG-1 [92]
and the effectors TRAF2 and TRAF6, which are re-
quired for the activation of NF-kB [88]. The NF-kB
and interferon responses are critical for the cellularproduction of cytokines that alert the body to a viral in-
fection. Interestingly, upon binding to TRAF2 and
TRAF6, MAVS enters into a detergent resistant micro-
domain on the mitochondria, which regulates the effi-
cacy of the downstream signaling cascades [88]. In
an interesting twist, a protease encoded by the hepa-
titis C virus was shown to cleave MAVS, releasing it
from the mitochondrial membrane and interfering
with the host cell viral response [91]. Unexpectedly,
these data place the mitochondria in the center of a sig-
nal transduction cascade that seemingly has no partic-
ular requirement for increased ATP consumption.
Mitochondria as a Signaling Platform
One explanation for the utilization of the mitochondrial
surface in the propagation of signaling cascades is the
possibility that the mitochondrion provides a unique
membrane environment for the assembly of dynamic
complexes (Figure 2). The lateral movement of MAVS
into a detergent-resistant microdomain is consistent
with this notion. Given that the lipid composition of
the mitochondria is distinct from those found on the
plasma membrane, the nature of the microdomain
must be unique. High levels of cardiolipin in the inner
membrane, for example, clearly distinguish this bilayer
from all others. The lipid ceramide has been shown to
form microdomains that can lead to channel formation
during apoptosis [93,94], and the ganglioside GD3,
which is derived from ceramide, has also been shown
to translocate to mitochondrial microdomains during
cell death [95,96]. Interestingly, GD3 has been shown
to interfere with the activation of NF-kB through un-
known mechanisms [97]. It is possible that GD3 inser-
tion in the mitochondrial outer membrane interferes
with the translocation of MAVS into a functional raft,
thereby inhibiting the NF-kB survival response.
Functional microdomains may also form on the
mitochondria through the lateral recruitment and am-
plification of phosphatidylinositol phosphates (PIPs),
activated Rab GTPases, and/or protein scaffolds. Al-
though the identity of specific species of PIPs on the
mitochondria has not been clearly demonstrated, mi-
tochondria do contain enzymes that modulate the for-
mation of PIPs. There are at least two mitochondrial PI
(5) phosphatases — synaptojanin 2A [98] and Inpp5B
[99] — and interference with synaptojanin 2A recruit-
ment has been shown to affect mitochondrial morphol-
ogy [98]. Rab GTPases are known to recruit a variety
of effectors, including PI kinases, phosphatases, and
regulators of motility, docking and fusion [100–102].
The recruitment of these effectors contributes to the
formation of functional microdomains on almost all
types of intracellular membrane. Two Rab GTPases
have been linked to mitochondrial function. In mam-
mals, Rab32 is recruited to the outer membrane, where
it binds protein kinase A in order to modulate mito-
chondrial morphology through as yet unknown mech-
anisms [103]. The yeast Rab GTPase Ypt11p binds to
the myosin V actin motor Myo2p, and both Ypt11p
and Myo2p are required to tether mitochondria within
the growing bud during cell division [104]. Although
our understanding of the role of Rab GTPases in mito-
chondrial function remains limited, it is likely that they
contribute to the formation of functional surface micro-
domains and mitochondrial activity (Figure 2).
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Figure 2. Assembly of lipid and protein
microdomains on mitochondrial mem-
branes. (A) Once activated by binding to
viral dsRNA, the RIG-1 adaptor protein
promotes incorporation of MAVS into de-
tergent-resistent domains on mitochon-
drial membranes. From these raft-like do-
mains, MAVS, together with TRAF2 and
TRAF6, coordinates signals leading to
NF-kB and IFNa/b activation. (B) PI phos-
phatases synaptojanin 2a and Innp5b and
unknown PIP kinases potentially deter-
mine the composition of PIPs on mito-
chondrial membranes. The recruitment of
these enzymes may be mediated through
the action of regulatory enzymes like
Rab32. The resulting enrichment in spe-
cific phosphorylated lipid species would
act as a binding platform for dynamic pro-
tein complex assembly. (C) Oligomeric
proteins like DRP1 localize to punctate
foci on the mitochondrial surface. In yeast
actin remodeling on mitochondrial mem-
branes is performed by the Arp2/3 com-
plex, and in the mammalian system actin
promotes stable DRP1 association with
mitochondrial membranes during stimu-
lated fission. The hypothetical participation of underlying PIP domains in the assembly of DRP1 and actin polymerization is indicated
by an arrow. Solid lines indicate protein interactions and reaction pathways, dotted lines represent protein and metabolite translocation
events. See text for details and references.Actin polymerization on the surface of intracellular
membranes is also known to provide a stable platform
for the assembly of protein complexes [105]. In yeast,
the actin-nucleating complex Arp2/3 is recruited to
punctate spots on the mitochondrial surface where it
mediates anterograde mitochondrial motility along ac-
tin cables [106–108]. In mammals, the increased stabi-
lization of DRP1 on mitochondria upon stimulation of
fission is also regulated in part by actin polymerization
[109]. Together, this indicates that actin patches, in
combination with both lipid raft and PIP-rich domains,
may modulate the assembly of diverse functional com-
plexes on the mitochondrial surface.
Mitochondria and Development
The mitochondrial network displays remarkable plas-
ticity during development of certain tissues. For exam-
ple, electron microscopy studies have revealed a tran-
sition from elliptical and rod-like mitochondria in
embryonic rat myocardiocytes and skeletal muscle
cells to an interconnected reticulum in the cardiac mus-
cle and diaphragm of adult animals [110–113]. This
morphological transition possibly reflects timed induc-
tion of mitochondrial fusion. Supporting this idea, ex-
pression levels of Mfn2 increase during differentiation
of myoblasts [36] and spermatocytes [114], correlating
with the extensive mitochondrial remodeling observed
in these cells.
The loss of either Mfn1 or Mfn2 is embryonic lethal,
highlighting the importance of mitochondrial dynamics
during development [3]. Interestingly, the Mfn2 null em-
bryos appear relatively normal, but are resorbed by
embryonic day 11.5 due to unsuccessful placental im-
plantation. Conversely, Mfn1 null embryos, although
developmentally delayed and resorbed by embryonic
day 12.5, display normal implantation, suggesting that
the placental malfunction observed in Mfn2 null miceis not directly related to a lack of mitochondrial fusion
[3]. This is consistent with the emerging evidence
that, in addition to its requirement for mitochondrial fu-
sion, Mfn2 has additional roles both in protection from
cell death [7,115,116] and in the regulation of metabo-
lism [26,36,38]. In contrast, the data so far indicate that
Mfn1 functions primarily as a core essential compo-
nent of the fusion machinery. It has been shown that
the heptad repeats of Mfn1 tether mitochondria to-
gether [4,5] and that Mfn1, but not Mfn2, participates
with Opa1 in the fusion process [11]. In addition, the nu-
cleotide-binding properties of Mfn1 and Mfn2 appear
to be quite distinct, suggesting unique functional prop-
erties [5]. Mfn1 binds to nucleotide with low affinity and
shows high rates of hydrolysis for GTP, consistent with
its evolutionary relationship to the dynamin family of
GTPases [5]. Although Mfn1 and Mfn2 have 60% se-
quence identity, Mfn2 binds nucleotides with high af-
finity and exhibits slow intrinsic hydrolysis rates remi-
niscent of the Rab family of regulatory GTPases [5,7].
Collectively, these findings strongly indicate that
Mfn1 and Mfn2 are functionally distinct GTPases that
are both essential for mitochondrial fusion and embry-
onic development.
Mitochondrial Responses in Neuronal Function
The genetic and cell biology systems used by neurobi-
ologists have provided important new insights into the
functional requirement and spatial positioning of mito-
chondria in polarized neurons both during develop-
ment and within the adult. For example, recent exper-
iments showed that local administration of nerve
growth factor (NGF) to an axon of a primary neuron in
culture increases mitochondrial movement into the
stimulated region and triggers the arrest of antero-
grade-directed mitochondria. This arrest results in
the accumulation of mitochondria within the vicinity
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upon activation of PI 3-kinase and actin polymerization
[117]. These data imply that a signal transduction cas-
cade downstream from TrkA results in the modulation
of mitochondrial motility in active growth cones of de-
veloping neurons [117]. Interestingly, the actin-remod-
elling GTPase RhoA and its formin effector mDia1 play
a role in the regulated arrest of mitochondrial motility in
mammalian cells and in a Drosophila neuronal cell line
[118], providing molecular cues responsible for actin-
mediated modifications of mitochondrial movement.
Mitochondria are highly responsive to synaptic stim-
ulation. In hippocampal neurons, dendritic mitochon-
dria rapidly fragment and cluster in the proximity of
dendritic spines in response to neuronal activity
[119]. Activity also decreases mitochondrial motility,
arguing for the existence of specific signals regulating
mitochondrial behavior. Interestingly, overexpression
of DRP1 results in an increased number of mitochon-
dria within the dendrite, as well as an increased density
of dendritic spines and synapses [119]. Conversely,
expression of a dominant-negative DRP1 mutant re-
sults in fused mitochondria that remain primarily within
the soma, resulting in very few mitochondria migrating
into the dendrite [119]. Depletion of dendritic mito-
chondria upon expression of the mutant DRP1 has
an adverse effect on spine development, suggesting
that mitochondrial function is required and limiting
for the formation and maintenance of synapses.
In the adult neuron, mitochondria are enriched at the
synapse, which is commonly explained by the impor-
tant functional role of mitochondria in buffering cal-
cium fluxes during synaptic transmission and provid-
ing energy for synaptic vesicle release and recycling.
However, experiments designed to remove mitochon-
dria selectively from the synapse suggest that many of
these assumptions are overly simplistic. Mutations in
DRP1 in Drosophila are semilethal, with the survivors
suffering neurodegeneration and lack of coordination
(termed the Fratboy mutant) [120]. The mitochondria
within mutant neurons are clustered and fused within
the soma, with few migrating into synapses. Interest-
ingly, although the resting cytosolic calcium within
these synapses is increased, neurotransmitter release
remains normal upon calcium stimulation. In addition,
synaptic vesicle endocytosis proceeds normally, indi-
cating that, even in mitochondria-depleted terminals,
there is sufficient energy to drive this process. Intrigu-
ingly, prolonged stimulation reveals defective migra-
tion of the reserve pool of synaptic vesicles to the
membrane [120]. This phenotype is due to a specific
requirement for mitochondrial ATP in the activation
of myosin motors required to mobilize the reserve
pool of vesicles to the plasma membrane. Since the
role of mitochondria in calcium buffering and local en-
ergy production has been well established, it is quite
surprising that these neurons are so functional in the
absence of mitochondria.
Mutations in Drosophila Miro1, an integral outer
membrane protein with two Rho-like GTPase domains
and calcium-binding EF hand motifs result in a loss of
anterograde mitochondrial delivery into the axon [121].
Flies lacking dMiro1 die at the larval stage due to nu-
merous defects, and the mitochondrial distribution inmuscles and neurons is limited to the cell body. Similar
to the DRP1 mutants, both basal and fast calcium-
stimulated neurotransmission are relatively normal,
with functional defects observed mainly upon chronic
stimulation. At the neuromuscular junction, the presyn-
aptic boutons in the dMiro mutants are more abundant,
smaller, structurally deformed and positioned close
together. The increase in synaptic boutons in the
absence of mitochondria is unexpected and also in
contrast with the observed decrease in dendritic
spines observed in mitochondria-depleted neurons
expressing mutant DRP1 [119]. In general, the seem-
ingly complex involvement of mitochondria in develop-
mental processes suggests that the positioning of the
mitochondria may be selectively required for the prop-
agation of developmental signaling cascades. Future
experiments will certainly shed more light on these ex-
citing new aspects of mitochondrial function.
Conclusions and Perspectives
This review has focused on the idea that the mitochon-
dria are intimately embedded in the signaling cascades
and programs that operate within the cell. Evidence is
emerging that these links include functions that extend
beyond the primary role of mitochondria as ATP gener-
ators. We have supplied examples to illustrate mecha-
nisms by which the mitochondria can receive cellular
signals and propagate a targeted response. These ex-
amples include intuitive responses, such as altering
the position of mitochondria within the cell in order to
provide a local ATP supply, but also more surprising
responses, such as the control of cell cycle and the dy-
namic modulation of respiratory capacity. In many
cases, we have suggested that the interface between
the cellular signal and mitochondrial response hinges
upon the activity of a new cast of proteins that mod-
ulates mitochondrial morphology and movement.
Some of these proteins appear to be unique mitochon-
drial proteins and enzymes, and others derive from the
more familiar families of proteins, such as GTPases,
lipid-modifying enzymes, kinases and phosphatases
(Table S1).
By delving into the complex interconnected nature
of mitochondria and cellular physiology, we will con-
tribute to the development of intelligent treatment
strategies for diseases characterized by mitochondrial
dysfunction. Many of these diseases result from muta-
tions in proteins that modulate mitochondrial behavior.
Mutations in Mfn2 result in the disease Charcot-Marie
Tooth Type 2A, characterized by a loss of peripheral
motor neurons [122], and mutations in Opa1 (and re-
cently also Mfn2) are responsible for autosomal domi-
nant optic atrophy, causing progressive blindness
[8,123]. Similarly, understanding the links to cell cycle
and apoptosis will provide new concepts in the treat-
ment of cancer, and the emerging understanding of
the kinases and phosphatases involved in Parkinson’s
disease will shed new light on neurodegenerative con-
ditions. In addition to the monogenic mitochondrial
diseases, a better understanding of dynamic meta-
bolic regulation will help to control diabetes, obesity,
and complex mitochondrial myopathies. The funda-
mental insights to be gained through the investigation
of dynamic mitochondrial function and the integration
Review
R558of this organelle in cell signaling pathways will have
far-reaching implications in many areas of biology.
Supplemental data
A supplemental table listing the proteins that modulate
mitochondrial morphology and signaling is available at http://
www.current-biology.com/cgi/content/full/16/14/R551/DC1/.
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